{"title":"The immunization of children with combined diphtheria and tetanus vaccine in Sweden","authors":"Kerstin Larsen , Karin Ullberg-Olsson , Birgitta Wickbom , Bengt Hederstedt","doi":"10.1016/0092-1157(87)90033-3","DOIUrl":null,"url":null,"abstract":"<div><p>Two groups derived from 97 children three-four months of age were vaccinated with diphtheria and tetanus vaccines containing either a routinely prepared diphtheria toxoid or a more purified preparation. Two injections were given with an interval of one month and a third injection was given one year after the first.</p><p>Prior to the third injection no child was without protection against diphtheria, i.e. had an antitoxin titre <0·01 IU ml<sup>−1</sup>. After the third injection 95 and 94% of the children vaccinated with the routinely and more purified diphtheria toxoids, respectively, had diphtheria antitoxin titres >1 IU ml<sup>−1</sup> (estimated to provide protection for at least ten years).</p><p>Systemic reactions such as fever and malaise occurred in five children. Local reactions >10 cm were observed in three children and reactions >5 but ⩽10 cm were seen in 14% of the children.</p><p>The routinely prepared combined diphtheria and tetanus vaccine, DT, produced very good immunity against diphtheria with moderate side effects. The use of a more purified diphtheria toxoid in the combined vaccine produced the same immunity and side effects.</p></div>","PeriodicalId":75991,"journal":{"name":"Journal of biological standardization","volume":"15 2","pages":"Pages 103-107"},"PeriodicalIF":0.0000,"publicationDate":"1987-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0092-1157(87)90033-3","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of biological standardization","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/0092115787900333","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 5
Abstract
Two groups derived from 97 children three-four months of age were vaccinated with diphtheria and tetanus vaccines containing either a routinely prepared diphtheria toxoid or a more purified preparation. Two injections were given with an interval of one month and a third injection was given one year after the first.
Prior to the third injection no child was without protection against diphtheria, i.e. had an antitoxin titre <0·01 IU ml−1. After the third injection 95 and 94% of the children vaccinated with the routinely and more purified diphtheria toxoids, respectively, had diphtheria antitoxin titres >1 IU ml−1 (estimated to provide protection for at least ten years).
Systemic reactions such as fever and malaise occurred in five children. Local reactions >10 cm were observed in three children and reactions >5 but ⩽10 cm were seen in 14% of the children.
The routinely prepared combined diphtheria and tetanus vaccine, DT, produced very good immunity against diphtheria with moderate side effects. The use of a more purified diphtheria toxoid in the combined vaccine produced the same immunity and side effects.
来自97名3 - 4个月大的儿童的两组接种了白喉和破伤风疫苗,其中含有常规制备的白喉类毒素或更纯化的制剂。两次注射间隔一个月,第三次注射在第一次注射后一年进行。在第三次注射之前,没有儿童没有白喉保护,即抗毒素滴度为0.01 IU ml−1。在第三次注射后,分别接种常规白喉类毒素疫苗和纯化白喉类毒素疫苗的儿童中,95%和94%具有1 IU ml - 1的白喉抗毒素滴度(估计可提供至少10年的保护)。5名儿童出现全身反应,如发热和不适。3例患儿出现局部反应>10 cm, 14%患儿出现反应>5 ~≤10 cm。常规制备的白喉和破伤风联合疫苗(DT)对白喉产生了很好的免疫力,副作用适中。在联合疫苗中使用更纯净的白喉类毒素产生了相同的免疫力和副作用。